GSK raises profit outlook on strong vaccine, HIV drug sales
Pfizer beats Q1 forecast despite 20% revenue drop, cuts four pipeline programs
Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
As AI proliferates in pharma, regulators look to catch up in clinical trials
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
Pfizer beats Q1 forecast despite 20% revenue drop, cuts four pipeline programs
Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
As AI proliferates in pharma, regulators look to catch up in clinical trials
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud